Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Oncopeptides AB. (6/27/19). "Press Release: Oncopeptides Intends to Make a Directed Share Issue [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]".

Organisations Organisation Oncopeptides AB (Nasdaq Stockholm: ONCO)
  Group Oncopeptides (Group)
  Organisation 2 Carnegie Investment Bank AB
Products Product Melflufen
  Product 2 investment banking
Index term Index term Oncopeptides–SEVERAL: investment, 201906 directed share issue SEK727m ($78m) of 5.015m new shares at SEK145/share
Persons Person Lindberg, Jakob (Oncopeptides AB 202102 CSO before CEO)
  Person 2 Piir, Rein (Oncopeptides 201912 Head of Investor Relations)
     


   
Record changed: 2019-12-04

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Oncopeptides (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top